Home Search
pancreatic cancer - search results
If you're not happy with the results, please do another search
Obesity to overtake smoking as biggest preventable cause of cancer in the UK
According to Cancer Research UK, obesity is predicted to surpass smoking as the biggest preventable cause of cancer in the UK for women by...
Breaking tolerance: improving cancer immunotherapy
The group of Dr Maija Hollmén at Turku University, Finland, attempts to make cold tumours hot by targeting the tumour-supporting functions of innate immune...
Oesophageal cancer can be prevented by taking two medications
Taking a combination of an anti-reflux medication and a low dose of aspirin can prevent oesophageal cancer in people at higher risk, according to...
New oral drug can protect cancer patients from venous thromboembolism
Taking one tablet a day could be the key to helping treat cancer patients and protect them from venous thromboembolism (VTE), according to research...
Weight loss is an important predictor of cancer
New research analysis from the universities of Oxford and Exeter has concluded that unintended weight loss is the second highest risk factor for some...
Leukaemia anti-cancer drug may work against rare ovarian cancer
A study has found that an anti-cancer drug, ponatinib, which is used to fight leukaemia, has shown promise in tackling a rare and aggressive...
CRUK announces £45m investment in cancer clinical trials
Cancer Research UK is to invest £45m (~€50.8m) into its network of cancer clinical trials units (CTUs) across the UK, one of the charity’s...
Defence Therapeutics strengthens and expands global patent protection on key technologies
Defence Therapeutics Inc. has announced the issuance of several new patents and new allowances of patent applications belonging to different Patent Families in Defence’s...
The health and economic impacts of digestive diseases across Europe
Helena Cortez-Pinto, President of United European Gastroenterology, discusses findings from White Book 2 which validate the need to better address the burden of digestive...
Are cannabinoid therapies the future of chronic pain management?
Health Europa Quarterly spoke to Dr Mikael Sodergren who leads the Medical Cannabis Research Group at Imperial College London about his research on novel...
Transforming our approach to disease prevention through health research
Our Future Health - the UK’s largest ever health research programme - explains how it aims to transform the prevention, detection, and treatment of...
Project launched to create Type 3c diabetes blood test
A new research partnership has been launched with the aim of developing a blood test to detect Type 3c diabetes.
The University of Liverpool has...
Novel method for enhancing tumours’ response to treatment
A team of researchers have innovated a new strategy that increases tumour receptiveness to cancer drugs, potentially augmenting the effectiveness of chemotherapy treatments.
The research,...
Health Europa Quarterly Issue 15
Welcome to the 15th issue of Health Europa Quarterly, which focuses on the prevention and control of the spread of infection and disease as...
Health Europa Quarterly Issue 12
Welcome to the 12th edition of Health Europa Quarterly, which takes as its key focus the rise of digital health solutions and the need...
Results through research: shaping the future of medical cannabis
Discover how, together, EMMAC Life Sciences and Imperial College London are advancing our understanding of the therapeutic properties of medical cannabis for a range...
KRAS protein mutations have varied effects on protein functions
A new study suggests that the effects of the KRAS protein mutations that underlie many different types of cancer are more diverse than previously...
The timing of immunotherapy
The Departments of Surgery and Molecular Cell Biology & Immunology, VU University Medical Center, Amsterdam, explore how immunotherapy can be used to fight against...
What went wrong in the UK National Health Service report?
In an analysis of international health systems, the UK’s National Health Service (NHS) has received a mixed scorecard; what did the results show?
In light...
Defying the odds – my journey to becoming a Highly Cited Researcher
Professor Eun-Jung Park chronicles her path from a ‘young child from a poor family in South Korea’ to a celebrated scientist and Highly Cited...